drugset / Trial / NCT05168930
Zanubrutinib and Venetoclax in CLL (ZANU-VEN)
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study is being done to test the effectiveness of zanubrutinib in combination with venetoclax in participants with previously treated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
Timeline
- Start
- 2022-02-18
- Primary completion
- 2026-10-28
- Completion
- 2028-10-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Venetoclax | Small molecule | — | — |
| Subject | Zanubrutinib | Small molecule | — | — |